Cutaneous manifestations in patients positive for anti-hepatitis C virus antibodies

Acta Dermato-Venereologica

Volumn 87, Issue 1, 2007, Pages 49-53

  Soylu, Seçil ^a,b   Gül, Ülker ^a   Kiliç, Arzu ^a  

^a Ankara Numune Training and Research Hospital   (Turkey)

^b Ankara Numune Education and Investigation Hospital   (Turkey)

Author keywords

Hepatitis C virus; Hepatitis C virus ribonucleic acid; Skin

Indexed keywords

VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; PRIORITY JOURNAL; PRURITUS; RISK FACTOR; SKIN DISEASE; SKIN EXAMINATION; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PRURITUS;

EID: 33846862700     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0186     Document Type: Article

References (39)

1. World Health Organization. Hepatitis C: global prevalence. Wkly Epidemiol Rec 1997; 72: 341-344.
2. Davis GL. Hepatitis C. In: Schiff ER, Sorrell MF, Maddrey WC, editors. Schiff's diseases of the liver. Philadelphia: Lippincott Williams and Wilkins, 2003, p. 807-844.
3. Bonkovsky HL, Mehta S. Hepatitis C: a review and update. J Am Acad Dermatol 2001; 44: 159-179.
4. Hadziyannis SJ. Skin diseases associated with hepatitis C virus infection. J Eur Acad Dermatol Venereol 1998; 10: 12-21.
5. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. Medicine 2000; 79: 47-56.
6. Paoletti V, Mammarella A, Basili S, Paradiso M, Di Franco M, De Matteis A, et al. Prevalence and clinical features of skin diseases in chronic HCV infection. A prospective study in 96 patients. Panminerva Med 2002; 44: 349-352.
7. Mangia A, Andriulli A, Zenarola P, Lomuto M, Cascavilla I, Quadri R, et al. Lack of hepatitis C virus replication intermediate RNA in diseased skin tissue of chronic hepatitis C patients. J Med Virol 1999; 59: 277-280.
8. Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19: 841-848.
9. Dervis E, Serez K. The prevalence of dermatological manifestations related to chronic hepatitis C virus infection in a study from a single center in Turkey. Acta Dermatovenereol Alp Panonica Adriat 2005; 14: 93-98.
10. Doutre MS. Hepatitis C virus-related skin diseases. Arch Dermatol 1999; 135: 1401-1403.
11. Pessoa MG, Fox RK, Wright TL. Extrahepatic manifestations of hepatitis C. In: Schiff ER, Sorrell MF, Maddrey WC, editors. Schiff's diseases of the liver. Philadelphia: Lippincott Williams and Wilkins, 2003, p. 905-916.
12. Ramos-Casals M, Trejo O, Garcia-Carrasco M, Font J. Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. Rheumatology 2003; 42: 818-828.
13. Manna R, Todaro L, Latteri M, Gambassi G, Massi G, Grillo MR, et al. Leucocytoclastic vasculitis associated with hepatitis C virus antibodies. Br J Rheumatol 1997; 36: 124-125.
14. Abe Y, Tanaka Y, Takenaka M, Yoshida H, Yatsuhashi H, Yano M. Leucocytoclastic vasculitis associated with mixed cryoglobulinaemia and hepatitis C virus infection. Br J Dermatol 1997; 136: 272-274.
15. Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin lmmunopathol 1997; 19: 111-129.
16. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-1495.
17. Mayo MJ. Extrahepatic manifestations of hepatitis C infection. Am J Med Sci 2002; 325: 135-148.
18. Sanchez-Perez J, De Castro M, Buezo GF, Fernandez-Herrera J, Borque MJ, Garcia-Diez A. Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection. Br J Dermatol 1996; 134: 715-719.
19. Dupin N, Chosidow O, Lunel F, Fretz C, Szpirglas H, Frances C. Oral lichen planus and hepatitis C virus infection: a fortuitous association. Arch Dermatol 1997; 133: 1052-1053.
20. Jubert C, Pawlotsky JM, Pouget F, Andre C, DeForges L, Bretagne S, et al. Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol 1994; 130: 73-76.
21. Nagao Y, Sata M, Ide T, Suzuki H, Tanikawa K, Itoh K, Kameyama T. Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C. Eur J Clin Invest 1996; 26: 1171-1174.
22. Cribier B, Garnier C, Laustriat D, Heid E. Lichen planus and hepatitis C virus infection: an epidemiologic study. J Am Acad Dermatol 1994; 31: 1070-1072.
23. Erkek E, Bozdogan O, Olut AI. Hepatitis C virus infection prevalence in lichen planus: examination of lesional and normal skin of hepatitis C virus-infected patients with lichen planus for the presence of hepatitis C virus RNA. Clin Exp Dermatol 2001; 26: 540-544.
24. Gül Denli Y, Durdu M, Karakaş M. Diabetes and hepatitis frequency in 140 lichen planus cases in Çukurova region. J Dermatol 2004; 31: 293-298.
25. Izumi T, Sasaki R, Tsunoda S, Akutsu M, Okamoto H, Miura Y. B cell malignancy and hepatitis C virus infection. Leukemia 1997; 11 Suppl 3: 516-518.
26. Michaelis S, Kazakov DV, Schmid M, Dummer R, Burg G, Kempf W. Hepatitis C and G viruses in B-cell lymphomas of the skin. J Cutan Pathol 2003; 30: 369-372.
27. Viguier M, Rivet J, Agbalika F, Kerviler E, Brice P, Dubertret L, et al. B-cell lymphomas involving the skin associated with hepatitis C virus infection. Int J Dermatol 2002; 41: 577-582.
28. Shimakage M, Sasagawa T, Kawahara K, Yutsudo M, Kusuoka H, Kozuka T. Expression of Epstein-Barr virus in cutaneous T-cell lymphoma including mycosis fungoides. Int J Cancer 2001; 92: 226-231.
29. Herne KL, Talpur R, Breuer-McHam J, Champlin R, Duvic M. Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sezary syndrome. Blood 2003; 101: 2132-2136.
30. Daoud MS, Hutton KP, Gibson LE. Cutaneous periarteritis nodosa: a clinicopathological study of 79 cases. Br J Dermatol 1997; 136: 706-713.
31. Kanazawa K, Yaoita H, Tsuda F, Murata K, Okamoto H. Association of prurigo with hepatitis C virus infection. Arch Dermatol 1995; 131: 852-853.
32. Dega H, Frances C, Dupin N, Lebre C, Simantov A, Callot C, et al. Pruritus and hepatitis C virus. The MULTIVIRC Unit. Ann Dermatol Venereol 1998; 125: 9-12.
33. Schwaber MJ, Zlotogorski A. Dermatologic manifestations of hepatitis C infection. Int J Dermatol 1997; 36: 251-254.
34. Kanazawa K, Yaoita H, Tsuda F, Okamoto H. Hepatitis C virus infection in patients with urticaria. J Am Acad Dermatol 1996; 35: 195-198.
35. Chouela E, Abeldano A, Panetta J, Ducard M, Neglia V, Sookoian S, et al. Hepatitis C virus antibody (anti-HCV): prevalence in psoriasis. Int J Dermatol 1996; 35: 797-799.
36. Kanazawa K, Aikawa T, Tsuda F, Okamoto H. Hepatitis C virus in patients with psoriasis. Arch Dermatol 1996; 132: 1391-1392.
37. Taglione E, Vatteroni ML, Martini P, Galluzzo E, Lombardini F, Delle Sedie A, et al. Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis. J Rheumatol 1999; 26: 370-372.
38. Graham-Brown RAC, Sarkany I. The hepatobiliary system and skin. In: Freedberg IM, Eisen AZ, Wolff K, editors. Fitzpatrick's dermatology in general medicine. New York: McGraw-Hill, 1999, p. 1918-1929.
39. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751-756.